Pedro Lichtinger's Net Worth
-$1.91 Million
Who is Pedro Lichtinger?
Pedro Lichtinger does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIOTIME INC, Gemphire Therapeutics Inc., Asterias Biotherapeutics, Inc., and OPTIMER PHARMACEUTICALS INC.
SEC CIK
Pedro Lichtinger's CIK is 0001470741
Past Insider Trading and Trends
2011 was Pedro Lichtinger's most active year for acquiring shares with 10 total transactions. Pedro Lichtinger's most active month to acquire stocks was the month of May. 2013 was Pedro Lichtinger's most active year for disposing of shares, totalling 4 transactions. Pedro Lichtinger's most active month to dispose stocks was the month of March. 2013 saw Pedro Lichtinger paying a total of $1,877,680.00 for 318,000 shares, this is the most they've acquired in one year. In 2013 Pedro Lichtinger cashed out on 296,000 shares for a total of $2,173,991.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOTIME INC (LCTX) Snapshot price: $0.8778
InvestorPedro Lichtinger owns 126,250 units of Common Shares, no par value which is worth $110,822.25. In the year 2009 Pedro Lichtinger acquired a total of 126,250 shares in BIOTIME INC at a cost of $24,850.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +1,920.00% | 120K |
—
|
—
| 126.25K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
∞
| 6.25K |
$3.98 | $24,850.00 | 6.25K |
Apr 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gemphire Therapeutics Inc. (NRBO) Snapshot price: $3.51
InvestorPedro Lichtinger owns 74,833 units of Common Stock which is worth $262,663.83. In the year 2016 Pedro Lichtinger filed a total of 6 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.07% | 15K |
—
|
—
| 74.83K |
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +21.43% | 10.56K |
$9.47 | $99,993.73 | 59.83K |
Mar 10
| |||
Form 4
|
∞
| 49.27K |
$7.37 | $363,367.52 | 49.27K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Asterias Biotherapeutics, Inc. No price found
President & CEOPedro Lichtinger owns 400,000 units of Series B Common Stock, par value $0.0001 per share and 528,205 units of Series A Common Stock, par value $0.0001 per share.acquired a total of 728,205 shares in Asterias Biotherapeutics, Inc. at a cost of $967,999.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| +32.05% | 128.21K |
$3.90 | $499,999.50 | 528.21K |
Feb 9
| |||
Form 4
| +100.00% | 200K |
$2.34 | $468,000.00 | 400K |
Jun 12
| |||
Form 4/A
|
∞
| 200K |
—
|
—
| 200K |
Jun 9
| |||
Form 4
|
∞
| 200K |
—
|
—
| 200K |
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OPTIMER PHARMACEUTICALS INC No price found
CEO and PresidentPedro Lichtinger owns 104,078 units of Common stock. From 2010 to 2013 Pedro Lichtinger acquired a total of 252,078 shares in OPTIMER PHARMACEUTICALS INC at a cost of $3,004,585.03, Pedro also disposed a total of 148,000 shares of OPTIMER PHARMACEUTICALS INC equalling to $2,173,991.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$13.69 | -$296,311.00 | 104.08K |
Apr 8
| |||
Form 4
| +11.82% | 11K |
$9.08 | $99,847.00 | 104.08K |
Nov 8
| |||
Form 4
| +2.40% | 2.19K |
$9.72 | $21,246.94 | 93.08K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
| +0.19% | 173 |
$9.72 | $1,682.25 | 90.89K |
Nov 15
| |||
Form 4
| +38.04% | 25K |
$8.98 | $224,450.00 | 90.72K |
Aug 4
| |||
Form 4
| +46.96% | 21K |
$11.89 | $249,690.00 | 65.72K |
Jun 30
| |||
Form 4
| +80.91% | 20K |
$12.34 | $246,800.00 | 44.72K |
May 27
| |||
Form 4
| +11.25% | 2.5K |
$7.71 | $19,273.75 | 24.72K |
May 16
| |||
Form 4
| +909.09% | 20K |
$12.34 | $246,800.00 | 22.2K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
∞
| 2.22K |
$7.71 | $17,115.09 | 2.22K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||